New cancer therapy eliminates toxic delivery vehicles for microRNA: Research
The research was funded by Pathway to Independence, the Purdue Centre for Cancer Research, the Indiana Clinical and Translational…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
RPG Life Sciences posts reduction in profit in Q1FY18
Domestic formulations sales impacted due to GST transition
Takeda Pharma partners with Cardurion Pharma
Takeda will jumpstart the new company’s discovery efforts by providing a 12-person cardiovascular research team from its Shonan,…
Arthritis drug may treat blood cancer patients
University of Sheffield scientists discover drug which offers an affordable and effective treatment
IDMA presents action plan for APIs to CDSCO
It also covered issues of APIs production, constraints faced by industry and guidelines to tackle emergency situations
Indian…
Lupin receives FDA approval for Rosuvastatin Calcium tablets
The medicine is indicated for the treatment of adult patients with hypertriglyceridemia
Pharmasafe India conference to be held in Mumbai
The event will aim to draw attention to the latest developments in the field of anti-counterfeiting technologies
BASF expands technical lab for pharma application & technology development in South Asia
The facility will cater to the fast-growing pharma market in South Asia
Lupin posts net profit at Rs 3,581 mn in Q1 FY 2018
EBITDA for the quarter was Rs 8,003 million compared to Rs 8,267 million in Q4 FY 2017
European Medicines Agency prepares for Brexit
Develops business continuity plan to handle workload implications and reallocate resources to maintain its priority activities
Zydus receives US FDA approval for Temozolomide capsules and Nadolol tablets
Both drugs to be manufactured at the company’s formulations manufacturing facility at the Pharma SEZ, Ahmedabad
Glenmark’s Acyclovir Ointment USP, 5% receives ANDA approval
Acyclovir Ointment USP, 5 per cent is the generic version of Zovirax Ointment, 5 per cent
Piramal Enterprises’ net profit up by 31 per cent in Q1 FY 2018
Consistently delivering excellent set of results quarter after quarter
India set to block $1.3 bn Gland Pharma-Fosun deal : Report
The deal was announced last July when Shanghai Fosun agreed to buy an 86 per cent stake in KKR & Co-backed Gland Pharma
Glenmark reports positive data in Phase 2a Study of GBR 830
GBR 830 is an investigational, first-in-class, Anti-OX40 Monoclonal Antibody
Torrent Pharma’s revenue dips in Q1 FY 2017-18
In Q1 2017-18, company posts revenue of Rs 1,374 crores
AstraZeneca gets extension for Meronem withdrawal till Aug 31
Meronem is used for the treatment of serious infections in hospitalised patients
US FDA concludes Lupin’s Aurangabad facility inspection
US FDA issued one 483 observation but corrected during the inspections itself